Who owns IMPACT BIOMEDICAL INC?
- Ticker: IBO
- CUSIP Number: 45259l205
Tip: Access positions for across all investors
Analyze quarterly positions in Impact Biomedical with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Impact Biomedical stock
Who bought or sold IMPACT BIOMEDICAL INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Geode Capital Management | 1.2M | $546k | -1% | Jun 2026 |
|
| Vanguard Capital Management | 809k | $372k | 14% | Jun 2026 |
|
| State Street Corporation | 608k | $365k | 5053% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 589k | $271k | 1% | Jun 2026 |
|
| BlackRock | 260k | $130k | 0% | Jun 2026 |
|
| Northern Trust | 236k | $108k | -3% | Jun 2026 |
|
| Citadel Advisors | 50k | $23k | 100% | Jun 2026 |
|
| Vanguard Global Advisers | 32k | $15k | 0% | Jun 2026 |
|
| Jane Street | 25k | $11k | 100% | Jun 2026 |
|
| Two Sigma Investments | 17k | $7.9k | -54% | Jun 2026 |
|
| Mason & Associates | 10k | $4.6k | 0% | Jun 2026 |
|
| Morgan Stanley | 9.3k | $5.8k | 0% | Mar 2026 |
|
| UBS Group | 2.4k | $1.1k | -93% | Jun 2026 |
|
| Global Trust Asset Management | 1.8k | $835.916400 | 0% | Jun 2026 |
|
| Citigroup | 353.00 | $212.011800 | 100% | Mar 2026 |
|
| FMR | 292.00 | $133.998800 | 1% | Jun 2026 |
|
| Wells Fargo & Company | 224.00 | $102.995200 | 0% | Jun 2026 |
|
| Newbridge Financial Services Group | 86.00 | $39.998600 | 0% | Jun 2026 |
|
| Royal Bank of Canada | 32.00 | $0 | 0% | Jun 2026 |
|
| CWM | 28.00 | $16.998800 | 0% | Mar 2026 |
|
| Burk Holdings | 27.00 | $11.998800 | 0% | Jun 2026 |
|
| Danske Bank A/s | 3.00 | $0.999900 | 0% | Jun 2026 |
|
| Ronald Blue Trust | 1.00 | $0 | 100% | Jun 2026 |
|